ReviewThe Korean journal of internal medicine2017
CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Eun Ji Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papercites it